BML Capital Management, LLC - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 3, 2026, for the 2025 Q4 period, BML Capital Management, LLC held in its portfolio 16 assets valued at $115,689,485 (i.e. $115.69M).

The most valuable assets in the portfolio included: ACLARIS THERAPEUTICS INC ($42.89M), ATEA PHARMACEUTICALS INC ($26.74M), and ORAMED PHARMACEUTICALS INC ($9.03M).

The chart below shows the top 10 valuable assets, and the table below shows the top 16 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in BML Capital Management, LLC Portfolio

ACLARIS THERAPEUTICS INC

ATEA PHARMACEUTICALS INC

ORAMED PHARMACEUTICALS INC

INSTIL BIO INC

PMV PHARMACEUTICALS INC

CARMAX INC

KEZAR LIFE SCIENCES INC

TARGET CORP

CARVANA CO

OUTSET MED INC

BML Capital Management, LLC - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
ACLARIS THERAPEUTICS INC	14250000	42892500	COM
ATEA PHARMACEUTICALS INC	7490000	26739300	COM
ORAMED PHARMACEUTICALS INC	3167231	9026608	COM NEW
INSTIL BIO INC	645600	7101600	COM NEW
PMV PHARMACEUTICALS INC	5292000	6615000	COM
CARMAX INC	155000	5989200	COM
KEZAR LIFE SCIENCES INC	720787	4533750	COM NEW
TARGET CORP	37500	3665625	COM
CARVANA CO	150	2016000	CL A
OUTSET MED INC	543180	2015198	COM NEW
PLIANT THERAPEUTICS INC	1546137	1886287	COM
IMAGENEBIO INC	177026	1221479	COM
CONNECT BIOPHARMA HLDGS LTD	408887	1153061	SHS
WALMART INC	335	492450	COM
TESLA INC	1000	205000	COM
LISATA THERAPEUTICS INC	73348	136427	COM